Cargando…

Current status of ablative therapies for renal tumors

The increase in detection of small (≤ 4 cm) renal cortical neoplasms has made nephron-sparing surgery the new standard of care for T1a renal lesions. Advances in minimally invasive surgery have improved the surgical approach to these lesions to include laparoscopic partial nephrectomy and renal abla...

Descripción completa

Detalles Bibliográficos
Autores principales: Mues, Adam C., Landman, Jaime
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808656/
https://www.ncbi.nlm.nih.gov/pubmed/19955677
http://dx.doi.org/10.4103/0970-1591.57928
_version_ 1782176520370913280
author Mues, Adam C.
Landman, Jaime
author_facet Mues, Adam C.
Landman, Jaime
author_sort Mues, Adam C.
collection PubMed
description The increase in detection of small (≤ 4 cm) renal cortical neoplasms has made nephron-sparing surgery the new standard of care for T1a renal lesions. Advances in minimally invasive surgery have improved the surgical approach to these lesions to include laparoscopic partial nephrectomy and renal ablative therapies. In this review, we discuss the indications, outcomes, and potential complications of the commonly used ablative modalities in urologic practice. We will expand on renal cryoablation and review the mechanism of action, surgical approaches, and evidence based medicine using this modality.
format Text
id pubmed-2808656
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-28086562010-01-25 Current status of ablative therapies for renal tumors Mues, Adam C. Landman, Jaime Indian J Urol Symposium The increase in detection of small (≤ 4 cm) renal cortical neoplasms has made nephron-sparing surgery the new standard of care for T1a renal lesions. Advances in minimally invasive surgery have improved the surgical approach to these lesions to include laparoscopic partial nephrectomy and renal ablative therapies. In this review, we discuss the indications, outcomes, and potential complications of the commonly used ablative modalities in urologic practice. We will expand on renal cryoablation and review the mechanism of action, surgical approaches, and evidence based medicine using this modality. Medknow Publications 2009 /pmc/articles/PMC2808656/ /pubmed/19955677 http://dx.doi.org/10.4103/0970-1591.57928 Text en © Indian Journal of Urology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Symposium
Mues, Adam C.
Landman, Jaime
Current status of ablative therapies for renal tumors
title Current status of ablative therapies for renal tumors
title_full Current status of ablative therapies for renal tumors
title_fullStr Current status of ablative therapies for renal tumors
title_full_unstemmed Current status of ablative therapies for renal tumors
title_short Current status of ablative therapies for renal tumors
title_sort current status of ablative therapies for renal tumors
topic Symposium
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808656/
https://www.ncbi.nlm.nih.gov/pubmed/19955677
http://dx.doi.org/10.4103/0970-1591.57928
work_keys_str_mv AT muesadamc currentstatusofablativetherapiesforrenaltumors
AT landmanjaime currentstatusofablativetherapiesforrenaltumors